Impact on Postoperative Pain of Three Single-use Adult Supraglottic Airway Devices in Short General Anesthetic Under Controlled Ventilation

NCT03614598 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 546

Last updated 2025-11-17

No results posted yet for this study

Summary

The investigators hypothesize that incidence of pharyngolaryngeal postoperative pain caused by the I-gel and LMA-Suprême devices will be ≤ 5%

Conditions

  • Pharyngolaryngeal Postoperative Pain

Interventions

PROCEDURE

Insertion of LMA-UNIQUE(TM) device

LMA-UNIQUE(TM) single-use adult supraglottic airway device inserted during short general anesthesia under controlled ventilation

PROCEDURE

Insertion of LMA-SUPREME(TM) device

LMA-SUPREME(TM) single-use adult supraglottic airway device inserted during short general anesthesia under controlled ventilation

PROCEDURE

Insertion of I-GEL(R) device

I-GEL(R) single-use adult supraglottic airway device inserted during short general anesthesia under controlled ventilation

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Joël L'Hermite, MD · CHU Nimes

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-22
Primary Completion
2012-09-05
Completion
2012-09-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03614598 on ClinicalTrials.gov